Using the aforementioned markers, breast cancers can be classified into four subgroups: HR + /HER2–; HR + /HER2 + ; HR–/HER2 + and HR–/HER2– (triple-negative breast cancer, TNBC). This evidence concerns the gene ERBB2 and breast cancer.